Latest Articlesddd
The United States FDA granted Breakthrough Therapy Designation to AMT-061. The European Medicines Agency gave it …
Prohost Letter #428 End of the Year Decisions ~ Part 3 In Part 3 of this …
ImmunoGen & Biogen News About ImmunoGen ImmunoGen (IMGN) is a creator and developer of antibody-drug conjugates (ADCs) …
Halozyme Therapeutics (HALO) and argenx (ARGX) announced a global collaboration and license agreement offering argenx the right to use …
FDA Granted Rare Pediatric Disease Designation for RegenxBio’s Product RGX-181 for CLN2 RegenxBio RegenxBio (RGNX), a …
Merck (MRK) announced its Q4 2018 financial results. The firm outperformed itself and delighted us with regard …
AGENUS Agenus (AGEN) announced the upcoming launch of its Biotech Electronic Security Token (BEST); the first digital security …
Can a liquid biopsy test be accurate enough for physicians to rely on in differentiating between …
Now You See it, Now You Don’t Deliberate Omissions of Real Facts Real facts might be …
Prohost Letter #427 End of the Year Decisions ~ Part 2 As a result of the unexpected …
Data published in Cancer Immunology Research indicate monotherapy and combination opportunities for COM701, a first-in-class cancer …
Lipocine (LPCN), a specialty pharmaceutical company, announced that an approximately eight-week top-line study using LPCN 1144 …
On January 8, 2019 the osteoporosis monoclonal antibody Evenity (romosozumab) developed by Amgen and UCB was …
More good news came from Exelixis (EXEL). It was expected by many but not by those who …
Prohost Letter #426 End of the Year Decisions ~ Part 1 We decided to make this …
Exelixis collaborator, Daiichi Sankyo, Receives Regulatory Approval for MINNEBRO™ (Esaxerenone) Tablets for Hypertension in Japan Exelixis …
Gilead Sciences (GILD) has news that begins with an announcement today that Japan’s Ministry of Health, Labour and …
Earlier this month the U.S. Food and Drug Administration (FDA) granted Fast Track Designation for CTX001 for …
Why Loxo Oncology and Sage Therapeutics Have Occupied Today's Headline News LOXO Oncology Eli Lilly (LILY) announced its …
Rhythm Pharmaceuticals, Inc. (RYTM) is a biopharmaceutical company focused on the development and commercialization of therapeutics for …
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Accept Privacy policy
